nach oben

Erschienen in:

07.02.2014 | Zertifizierte Fortbildung

Gutartig oder bösartig?

Schilddrüsenknoten

verfasst von: Prof. Dr. med. Ralf Paschke

Erschienen in: Im Fokus Onkologie | Ausgabe 1-2/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Schilddrüsenknoten sind häufig. Aber können Sie immer mit Sicherheit ihre Dignität beurteilen? Hier erfahren Sie, wie Sie vorgehen sollten und welche Möglichkeiten heute in der modernen Diagnostik bestehen, um festzustellen, ob schnelles Handeln oder Warten und Beobachten angezeigt sind.

Gharib H et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract. 2010;16(Suppl 1):468–75.PubMedCrossRef

Paschke R et al. Epidemiologie, Pathophysiologie, leitliniengerechte Diagnostik und Therapie des Schilddrüsenknotens. Med Klin. 2010;105(2):80–7.CrossRef

Paschke R et al. Review of recently revised thyroid nodule guidelines - agreement, disagreement and need for future research. Nat Rev Endocrinol. 2011;7(6):354–61.PubMedCrossRef

Krohn K et al. Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev. 2005;26(4):504–24PubMedCrossRef

Baehre M et al. Physiological aspects of the thyroid trapping function and its suppression in iodine deficiency using 99mTc pertechnetate. Acta Endocrinol (Copenh). 1987;115(2):175–82.

Görges H. Szintigraphisch mehranreichernde Schilddrüsenknoten gehen überwiegend mit normwertigen TSH einher. Nuklearmedizin. 2011;50(3):179–88.PubMedCrossRef

Ashcraft MW, Van Herle AJ. Management of thyroid nodules. II: Scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head Neck Surg. 1981;3(4):297–322.PubMedCrossRef

Holzer S et al. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Cancer. 2000;89(1):192–201.

Cases JA, Surks MI. The changing role of scintigraphy in the evaluation of thyroid nodules. Semin Nucl Med. 2000;30(2):81–7.PubMedCrossRef

Kneafsey B et al. Limitations of thyroid scanning in solitary thyroid nodules. Ir J Med Sci. 1994;163(10):451–4.PubMedCrossRef

Paschke R. Abklärung des euthyreoten Schilddrüsenknotens: Wann punktieren? Stellenwert der Sonographie. Dtsch Med Wochenschr. 2009;134(49):2498–503.PubMedCrossRef

Knudsen N et al. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. Eur J Endocrinol. 2000;143(4):485–91.PubMedCrossRef

Engelhardt C et al. Prevalence of solitary hot, cold and normal functioning thyroid nodules in patients with first evaluation for a solitary thyroid nodule. Exp Clin Endocrinol Diabetes. 2005;113(Suppl. 1):35.

Frates MC et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology. 2005;237(3):794–800.PubMedCrossRef

Wienke JR et al. Sonographic features of benign thyroid nodules: interobserver reliability and overlap with malignancy. J Ultrasound Med. 2003;22(10):1027–31.PubMed

Moon WJ et al. Benign and malignant thyroid nodules: US differentiation - multicenter retrospective study. Radiology. 2008;247(3):762–70.PubMedCrossRef

Trimboli P et al. Ultrasound sensitivity for thyroid malignancy by real-time elastography: a prospective multicenter study. J Clin Endocrinol Metab. 2012;97(12):4524–30.PubMedCrossRef

Frates MC et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91(9):3411–7.PubMedCrossRef

Russ G et al. Prospective evaluation of thyroid imaging reporting and datasystem on 4550 nodules with and without elastography. Eur J Endocrinol. 2013;168(5):649–55.PubMedCrossRef

Danese D et al. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid. 1998;8(1):15–21.PubMedCrossRef

Yeh MW et al. False-negative fine needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid. 2004;14(3):207–15.PubMedCrossRef

Oertel YC et al. Value of repeated fine needle aspirations of the thyroid: an analysis of over ten thousand FNAs. Thyroid. 2007;17(11):1061–6.PubMedCrossRef

Kuma K et al. Outcome of long standing solitary thyroid nodules. World J Surg. 1992;16(4):583–7.PubMedCrossRef

Ferraz C et al. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab. 2011;96(7):2016–26.PubMedCrossRef

Eszlinger M et al. Perspectives for improved and more accurate classification of thyroid epithelial tumors. J Clin Endocrinol Metab. 2008;93(9):3286–94.PubMedCrossRef

Ferraz C et al. Detection of PAX8/PPARG and RET/PTC Rearrangements Is Feasible in Routine Air-Dried Fine Needle Aspiration Smears. Thyroid. 2012;22(10):1025–30.PubMedCrossRef

Ohori NP et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of ‚follicular lesion of undetermined significance/atypia of undetermined significance“. Cancer Cytopathol. 2010;118(1):17–23.PubMedCrossRef

Nikiforov YE et al. Molecular Testing for Mutations in Improving the Fine Needle Aspiration Diagnosis of Thyroid Nodules. J Clin Endocrinol Metab. 2009;94(6):2092–8.PubMedCrossRef

Moses W et al. Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg. 2010;34(11):2589–94.PubMedCentralPubMedCrossRef

Cantara S et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab. 2010;95(3):1365–9.PubMedCrossRef

Sapio MR et al. High growth rate of benign thyroid nodules bearing RET/PTC rearrangements. J Clin Endocrinol Metab. 2011;96(6):E916–9.PubMedCrossRef

Marotta V et al. Are RET/PTC rearrangements in benign thyroid nodules of biological significance?. Thyroid. 2010;20(10):1191–2.PubMedCrossRef

Marotta V et al. RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint. Eur J Endocrinol. 2011;165(4):499–507.PubMedCrossRef

Lang W et al. The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch A Pathol Anat Histol. 1980;385(2):125–41.PubMedCrossRef

Kamran SC et al. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab. 2013;98(2):564–70.PubMedCrossRef

Eszlinger M et al. Results of Mutation and Rearrangements Detection in Air Dried FNA Smears in a Routine Diagnostic Setting of Patients with Nodular Thyroid Disease. 56. Symposium der Deutschen Gesellschaft für Endokrinologie 2013; Freier Vortrag OP6–36.

Vasko V et al. Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab. 2003;88(6):2745–52.PubMedCrossRef

Kondo T et al. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer. 2006;6(4):292–306.PubMedCrossRef

Nikiforov YE et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011;96(11):3390–7.PubMedCrossRef

Elisei R et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab. 2008;93(10):3943–9.PubMedCrossRef

Elisei R et al. The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J Clin Endocrinol Metab. 2012;97(12):4390–8.PubMedCrossRef

Xing M et al. BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Biopsy Specimens for Preoperative Risk Stratification in Papillary Thyroid Cancer. J Clin Oncol. 2009;27(18):2977–82.PubMedCrossRef

Piana S et al. Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate?. Experience of over 18 000 FNAs reported at the same institution during 1998–2007. Cytopathology. 2011;22(3):164–73.

Yip L et al. Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J Clin Endocrinol Metab. 2012;97(6):1905–12.PubMedCrossRef

Titel: Gutartig oder bösartig?
Schilddrüsenknoten
verfasst von: Prof. Dr. med. Ralf Paschke
Publikationsdatum: 07.02.2014
Verlag: Urban & Vogel
Erschienen in: Im Fokus Onkologie / Ausgabe 1-2/2014
Print ISSN: 1435-7402
Elektronische ISSN: 2192-5674
DOI: https://doi.org/10.1007/s15015-014-0001-0

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Gutartig oder bösartig?

Schilddrüsenknoten

Zusammenfassung

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1-2/2014

Vorbehandeltes NSCLC: Zwei TKIs im Vergleich

Metastasiertes Kolorektalkarzinom: Nebenwirkungsmanagement von Regorafenib

HER2-positives Mammakarzinom: Antikörper-Therapie in Eigenregie

Antiemese-Prophylaxe an Leitlinien und individuellen Risikofaktoren orientieren

„Schulterschluss“ der Rezeptoren

mRCC: Patienten profitieren von Everolimus in der Zweitlinientherapie

Neu im Fachgebiet Onkologie

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

15% bedauern gewählte Blasenkrebs-Therapie

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Onkologie